Table 1.
Diagnostic category | Description | Criteria |
---|---|---|
1. Normal | ||
2. Antibody-mediated changes | C4d deposition without morphologic evidence of active rejection | C4d+; circulating DSA present; no signs of acute or chronic TCMR or ABMR |
Acute antibody-mediated rejection | C4d+; circulating DSA present; morphologic evidence of acute tissue injury such as acute tubular necrosis, capillaritis, and/or glomerulitis and/or thrombosis; severe arteritis (v3) | |
Chronic active antibody-mediated rejection | C4d+; circulating DSA present; morphologic evidence of chronic tissue injury such as glomerular double contours and/or peritubular capillary basement membrane multilayering; IF/TA; fibrous intimal thickening in arteries | |
3. Borderline change | “Suspicious” for acute T-cell-mediated rejection | No intimal arteritis (v0), but there are interstitial infiltrates and tubulitis insufficient to meet criteria for T-cell-mediated rejection (i0-i1, t1-t3 or i2-i3, t1) |
4. T-cell-mediated rejection (TCMR) | Acute T-cell-mediated rejection | Type I: i2-3, t2-3 Type II: v1-v2 Type III: v3 |
Chronic active T-cell-mediated rejection | Arterial intimal fibrosis with mononuclear cell infiltration in fibrosis, formation of neo-intima | |
5. Interstitial fibrosis and tubular atrophy | No evidence of any specific etiology | Severity graded I–III by the extent of tubulointerstitial fibrosis and atrophy |
6. Other | Changes not considered to be due to rejection | For example, acute pyelonephritis, BK polyoma virus interstitial nephritis |
Data adapted from Solez et al. (2008).